TuHURA Biosciences HURA
NASDAQ HURA
$2.00 -0.22 (-9.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Interest Expenses (2011 - 2026)

TuHURA Biosciences (HURA) posted quarterly Interest Expenses of $9.5 million for Q1 2026, up 703.04% year-over-year from $1.2 million in Q1 2025, and up 17172.73% quarter-over-quarter from $55000.0 in Q4 2025.

TuHURA Biosciences (HURA) Interest Expenses (2011 - 2026) Analysis & Trends

TuHURA Biosciences' Interest Expenses history runs 15 years deep, the most recent figure standing at $9.5 million for Q1 2026.

  • In Q1 2026, Interest Expenses rose 703.04% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (up 703.04% YoY), while the FY2025 annual figure was $625283.0, down 98.66% from the prior year.
  • Interest Expenses for Q1 2026 stood at $9.5 million, up from $55000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $46.5 million in Q4 2024, with the low at $55000.0 in Q4 2025.
  • The 4-year median for Interest Expenses is $1.6 million (2024), against an average of $10.8 million.
  • The sharpest annual moves came in 2025 and 2026: Interest Expenses slumped 99.88% in 2025, then soared 703.04% in 2026.
  • TuHURA Biosciences' Interest Expenses stood at $21.3 million in 2023, then surged by 118.27% to $46.5 million in 2024, then plunged by 99.88% to $55000.0 in 2025, then surged by 17172.73% to $9.5 million in 2026.
  • Business Quant data shows HURA's Interest Expenses at $9.5 million in Q1 2026, $55000.0 in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 39.74 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 82.05 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -4.89 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 20.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 93.62 Mn
10 TuHURA Biosciences 37.61 Mn 37.61 Mn - 467,634.00

Historic Data

Download Data
DateValue
Mar 31, 2026 9.50 Mn
Mar 31, 2026 9.50 Mn
Dec 31, 2025 55,000.00
Dec 31, 2025 55,000.00
Sep 30, 2025 1.09 Mn
Sep 30, 2025 1.09 Mn
Jun 30, 2025 1.31 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 1.18 Mn
Mar 31, 2025 1.18 Mn
Dec 31, 2024 46.49 Mn
Dec 31, 2024 46.49 Mn
Sep 30, 2024 3.62 Mn
Sep 30, 2024 3.62 Mn
Jun 30, 2024 1.61 Mn
Jun 30, 2024 1.61 Mn
Mar 31, 2024 255,122.00
Mar 31, 2024 255,122.00
Dec 31, 2023 21.30 Mn
Dec 31, 2023 21.30 Mn